MARATTO

review · Neurology

Efficacy of Arimoclomol for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis of Randomized Control Trials (P11-11.007)

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

This study aims to assess the efficacy of Arimoclomol in patients with amyotrophic lateral sclerosis (ALS)

Research topics

  • Amyotrophic Lateral Sclerosis Research
  • biodegradable polymer synthesis and properties
  • Parkinson's Disease Mechanisms and Treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1212/wnl.0000000000211977

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.